-
[1]
Guo-hui CHANG, Andrew Dividson, Lei LIN, Matt Wilson, Stuart G Siddell, Qing-yu ZHU, 2010: Establishment of the Eukaryotic Cell Lines for Inducible Control of SARS-CoV Nucleocapsid Gene Expression*, Virologica Sinica, 25, 361-368. doi: 10.1007/s12250-010-3124-2
-
[2]
Hong TIAN, Xiang-tao LIU, Jing-yan WU, You-jun SHANG, Tao JIANG, Hai-xue ZHENG, Qing-ge XIE, 2008: Expression of Major Antigen Domains of E2 Gene of CSFV and Analysis of its Immunological Activity *, Virologica Sinica, 23, 247-254. doi: 10.1007/s12250-008-2956-5
-
[3]
Zhongyu Zhu, Ponraj Prabakaran, Weizao Chen, Christopher C. Broder, Rui Gong, Dimiter S. Dimitrov, 2013: Human Monoclonal Antibodies as Candidate Therapeutics Against Emerging Viruses and HIV-1, Virologica Sinica, 28, 71-80. doi: 10.1007/s12250-013-3313-x
-
[4]
黄欣, 高亚萍, 王希良, 辛忠涛, 董洁, 邵宁生, 柳川, 2006: Screening and Identification of the SARS-CoV N Protein Epitopes, Virologica Sinica, 21, 314-318.
-
[5]
Yi ZHANG, Wei WANG, Jin-rong GAO, Li YE, Xiao-nan FANG, Ying-chun ZENG, Zheng-hui WU, Ying-long SHE, Lin-bai YE, 2007: The Functional Motif of SARS-CoV S Protein Involved in the Interaction with ACE2, Virologica Sinica, 22, 1-7.
-
[6]
Li-li XU, Zhi-hong HU, Hua-lin WANG, Xiao HAN, Fei DENG, 2009: Evaluation of Sensitivities and Specificities of SARS-CoV Detection by Real-time Quantitative Reverse Transcription-PCR Assays*, Virologica Sinica, 24, 187-193. doi: 10.1007/s12250-009-3021-8
-
[7]
杨杰华, 刁有祥, 于申业, 刘霞, 姜世金, 刘悦竹, 陈庆普, 2005: Isolation and Sequence Analysis of S1 Gene of Avian Infectious Bronchitis Virus A Field Strain, Virologica Sinica, 20, 283-287.
-
[8]
戴亚斌, 陈德胜, 潘杰彦, 姜焱, 刘兴友, 芦银华, 刘 梅, 丁 铲, 陈溥言, 蔡宝祥, 2002: Am plification,Cloning and Sequence Analysis of S1 Genes from Infectious Bronchitis Virus Isolates JS/95/03 and SD/97/01, Virologica Sinica, 17, 172-177.
-
[9]
赵振芬, 黄亚东, 王林川, 刘公平, 辛朝安, 2000: Study on RT-PCR/RFLP of Spike Protein S1 Gene of Avian Infectious Brochitis Virus H Strain, Virologica Sinica, 15, 197-199.
-
[10]
赵琳, 涂亦娴, 于杨, 金华利, 陈则, 王宾, 2006: Role of ORF7 in the Genome of SARS-CoV, Virologica Sinica, 21, 343-347.
-
[11]
Zezhong Liu, Shuai Xia, Xinling Wang, Qiaoshuai Lan, Wei Xu, Qian Wang, Shibo Jiang, Lu Lu, 2020: Inefficiency of Sera from Mice Treated with Pseudotyped SARS-CoV to Neutralize 2019-nCoV Infection, Virologica Sinica, 35, 340-343. doi: 10.1007/s12250-020-00214-5
-
[12]
彭宇, 李姝, 李朝阳, 王菁菁, 田波, 郭德银*, 2005: Interaction between Nucleocapsid Protein and the Leader the Sequence of SARS-CoV RNA, Virologica Sinica, 20, 490-493.
-
[13]
冯燕*, 卢亦愚, 严菊英, 史雯, 李敏红, 龚黎明, 葛琼, 周敏, 2005: Real-time Quantitative RT-PCR Assay for Quick Detection of SARS-associated Coronavirus RNA, Virologica Sinica, 20, 228-231.
-
[14]
Lok-Yin Roy Wong, Pak-Yin Lui, Dong-Yan Jin, 2016: A molecular arms race between host innate antiviral response and emerging human coronaviruses, Virologica Sinica, 31, 12-23. doi: 10.1007/s12250-015-3683-3
-
[15]
Shibo Jiang, Zheng-Li Shi, 2020: The First Disease X is Caused by a Highly Transmissible Acute Respiratory Syndrome Coronavirus, Virologica Sinica, 35, 263-265. doi: 10.1007/s12250-020-00206-5
-
[16]
宋延华, 刘福安, 1999: Preliminary Study on Expression Infectious Bronchitis Virus Level of the S1 Gene of Avian in a Baeulovirus System, Virologica Sinica, 14, 255-258.
-
[17]
何贤辉, 徐丽慧, 蔡小嫦, 曾耀英, , 2004: Construction of an Eukaryotic Expression Vector for SARS-CoV Sars7a and EGFP Fusion Protein Expression, Virologica Sinica, 19, 209-213.
-
[18]
马翠卿, 周育森, 王弋嘉, 郭彦, 管洁, 魏林, 何玉先, 2005: Expression and Immunogenicity Analysis of the Receptor-binding Region of SARS-CoV Spike Protein, Virologica Sinica, 20, 472-475.
-
[19]
Fang Fang Yuan, Zlatibor Velickovic, Lesley J Ashton, Wayne B Dyer, Andrew F Geczy, Heather Dunckley, Garry W Lynch, John S Sullivan, 2014: Influence of HLA gene polymorphisms on susceptibility and outcome post infection with the SARS-CoV virus, Virologica Sinica, 29, 128-130. doi: 10.1007/s12250-014-3398-x
-
[20]
Ke Wang, Yu Pan, Dianbing Wang, Ye Yuan, Min Li, Yuanyuan Chen, Lijun Bi, Xian-En Zhang, 2023: Altered hACE2 binding affinity and S1/S2 cleavage efficiency of SARS-CoV-2 spike protein mutants affect viral cell entry, Virologica Sinica, 38, 595-605. doi: 10.1016/j.virs.2023.06.005